Viewing Study NCT02738918


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2026-01-09 @ 11:18 PM
Study NCT ID: NCT02738918
Status: COMPLETED
Last Update Posted: 2019-07-05
First Post: 2016-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module